| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $0.1B | $0.1B | $0.1B | $0.1B | $0.0B | $0.0B | $0.0B | $0.0B |
| Operating Income | $0.2B | $0.3B | $0.4B | $0.4B | $0.4B | $0.2B | $0.2B | $0.2B |
| Net Income | $0.2B | $0.3B | $0.4B | $0.4B | $0.4B | $0.2B | $0.0B | $0.0B |
| EPS (Basic) | $0.56 | $1.18 | $1.79 | $1.72 | $2.30 | $1.44 | $0.35 | $0.48 |
| EPS (Diluted) | $0.56 | $1.18 | $1.75 | $1.67 | $2.28 | $1.41 | $0.34 | $0.47 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $14.5B | $13.5B | $15.7B | $17.0B | $15.1B | $7.7B | $6.2B | $4.6B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.5B | $0.5B | $0.9B | $0.5B | $0.4B | $0.3B | $0.3B | $0.2B |
| Total Liabilities | $11.4B | $10.3B | $12.5B | $14.0B | $12.5B | $6.2B | $4.9B | $3.5B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $3.0B | $3.0B | $3.1B | $2.9B | $2.4B | $1.3B | $1.2B | $0.9B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.4B | $0.5B | $0.2B | $1.1B | $0.2B | $0.1B | $-0.2B | $-0.0B |
| Investing Cash Flow | $-1.3B | $1.2B | $1.9B | $-2.3B | $-6.8B | $-1.2B | $-1.0B | $-0.7B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $0.8B | $-2.5B | $-1.8B | $1.6B | $6.9B | $1.1B | $1.4B | $0.8B |